Kurumboor 2012.

Methods	Randomised clinical trial (parallel design)
Participants	Country: India Number randomised: 45 Post‐randomisation drop‐outs: not stated Revised sample size: 45 Average age: not stated Females: not stated Malignancy: not stated Chronic pancreatitis: not stated Pancreatoduodenectomy: not stated Inclusion criteria: 1. People with soft pancreas undergoing pancreaticoduodenectomy
Interventions	Participants were randomly assigned to 2 groups Group 1: somatostatin analogue (n = 24) Further details: octreotide 100 μg sc Group 2: control (n = 21) Further details: no intervention
Outcomes	The outcomes reported were pancreatic fistula, overall complications and hospital stay
Notes	Attempts were made to contact the authors in February 2013 Pancreatic fistula definition: grade A, grade B and grade C reported separately
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment (selection bias)	Unclear risk	Comment: this information was not available
Blinding (performance bias and detection bias) All outcomes	Unclear risk	Comment: this information was not available
Incomplete outcome data (attrition bias) All outcomes	Unclear risk	Comment: this information was not available
Selective reporting (reporting bias)	Unclear risk	Comment: some important outcomes which will generally be assessed were not reported
Free of source of funding bias?	Unclear risk	Comment: this information was not available